Analyst Reco. Gilead Sciences, Inc. Sao Paulo

Equities

GILD34

BRGILDBDR000

Market Closed - Sao Paulo Other stock markets 11:21:12 10/05/2024 pm IST			5-day change	1st Jan Change
169.9 ^BRL	-1.92%		+3.77%	-11.73%

09/05	Declaration of Voting Results by Gilead Sciences	CI
09/05	Declaration of Voting Results by Gilead Sciences	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating	02/05	MT
Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75	01/05	MT
Maxim Adjusts Price Target on Gilead Sciences to $85 From $90	01/05	MT
Redburn Atlantic Adjusts Price Target on Gilead Sciences to $117 From $120	01/05	MT
Barclays Adjusts Price Target on Gilead Sciences to $76 From $80	29/04	MT
TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90	26/04	MT
Jefferies Adjusts Gilead Sciences' Price Target to $80 From $95	26/04	MT
RBC Capital Adjusts Gilead Sciences' Price Target to $74 From $76	26/04	MT
Morgan Stanley Adjusts Price Target on Gilead Sciences to $78 From $80	26/04	MT
North American Morning Briefing : More Tech -2-	25/04	DJ
HSBC Upgrades Gilead Sciences to Hold From Reduce, Price Target is $69	24/04	MT
Argus Cuts Price Target on Gilead Sciences to $75 From $85	23/04	MT
Cantor Fitzgerald Adjusts Gilead Sciences' Price Target to $75 From $78, Maintains Neutral Rating	22/04	MT
BMO Capital Adjusts Price Target on Gilead Sciences to $80 From $89	19/04	MT
Leerink Partners Adjusts Gilead Sciences Price Target to $74 From $79	19/04	MT
UBS Adjusts Gilead Sciences Price Target to $75 From $81, Maintains Neutral Rating	17/04	MT
Goldman Sachs Adjusts Gilead Sciences Price Target to $73 From $76	15/04	MT
Morgan Stanley Cuts Price Target on Gilead Sciences to $80 From $83, Keeps Equalweight Rating	09/04	MT
Wells Fargo Cuts Price Target on Gilead Sciences to $78 From $84, Keeps Equalweight Rating	04/03	MT
Mizuho Securities Cuts Price Target on Gilead Sciences to $90 From $101, Maintains Buy Rating	22/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Gilead Sciences, Inc. Sao Paulo

Equities

GILD34

BRGILDBDR000

Analyst Reco.

Filters